Anda belum login :: 23 Apr 2024 19:09 WIB
ArtikelCellular Cardiomyoplasty For Myocardial Infarction: a 2014 Evidence-based Update  
Oleh: Nursalim, Alvin ; Katili, Puspita A. ; Santoso, Teguh
Jenis: Article from Journal - ilmiah nasional - terakreditasi DIKTI
Dalam koleksi: Acta Medica Indonesiana vol. 46 no. 02 (Apr. 2014), page 150-162.
Topik: Stem Cells; Cellular Cardiomyoplasty; Myocardial Infarction
Fulltext: A02 v46 n2 p150 kelik2022.pdf (1.2MB)
  • Perpustakaan FK
    • Nomor Panggil: A02.K
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelMyocardial infarction is one of the main cause of mortality in many countries. Therefore, an effective therapy for myocardial infarction is required. Reperfusion and other conventional therapy have been the mainstay therapy for myocardial infarction. However, many patients remain refractory to this therapy. Cellular cardiomyoplasty is considered a novel therapy, in which stem cells are used for cardiac repair. Stem cells are potential therapeutic approach that could be the ultimate solution for salvaging damaged cardiomyocyte. Based on current studies, stem cells are a promising therapeutic approach for myocardial infarction. However, some challenges need to be answered by future studies before this novel therapy can be widely applied. As we advance our understanding, all questions behind stem cell therapy would finally be revealed, and eventually provide the ultimate solution for ischaemic cardiac repair. This paper provide an overview of the latest progress in stem cell therapy for myocardial infarction.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Process time: 0.03125 second(s)